CF
TLSIW icon

Cantor Fitzgerald’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Cantor Fitzgerald’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,658
Closed -$73.4K – 329
2023
Q4 		$73.4K Hold
61,658
– – 0.02% 162
2023
Q3 		$23.4K Hold
61,658
– – ﹤0.01% 491
2023
Q2 		$2.58K Hold
61,658
– – ﹤0.01% 553
2023
Q1 		$3.79K Buy
+61,658
New +$5.44K ﹤0.01% 651

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
EAM
Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald's TLSIW Position: Q1 2024 in Review

Cantor Fitzgerald sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2024, closing a stake of 61,658 shares — an estimated $73.4K sold.

Cantor Fitzgerald first reported a position in TLSIW in Q1 2023 and held it in 4 quarters. The position peaked at $73.4K in Q4 2023. 21 funds tracked by Wall St. Rank hold TLSIW as of Q1 2024.

  • Cantor Fitzgerald reported no remaining TriSalus Life Sciences Warrant position as of Q1 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 61,658 TriSalus Life Sciences Warrant shares in Q1 2024, an estimated $73.4K.
  • Cantor Fitzgerald first reported a position in TriSalus Life Sciences Warrant in Q1 2023 and held it in 4 quarters.
  • Cantor Fitzgerald's TriSalus Life Sciences Warrant position peaked at $73.4K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2024.

Based on Cantor Fitzgerald's 13F filing for Q1 2024, filed 15 May 2024.